Diagnostic Potential of the Plasma Lipidome in Infectious Disease: Application to Acute SARS-CoV-2 Infection
暂无分享,去创建一个
J. Nicholson | E. Holmes | N. Embade | J. Wist | Monique Ryan | L. Whiley | Sze-How Bong | Nicola Gray | N. Lawler | M. Bizkarguenaga | A. X. Zeng | Chiara Bruzzone | Berin A. Boughton | Ó. Millet | B. Boughton | Monique J. Ryan | C. Bruzzone | Luke Whiley
[1] Lanjuan Li,et al. Alterations in the human oral and gut microbiomes and lipidomics in COVID-19 , 2021, Gut.
[2] J. Nicholson,et al. Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses , 2021, Journal of proteome research.
[3] Chunbo Chen,et al. Lipidomic alteration of plasma in cured COVID-19 patients using ultra high-performance liquid chromatography with high-resolution mass spectrometry , 2021, Bioscience reports.
[4] G. Fabbrocini,et al. Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19 , 2021, Scientific Reports.
[5] P. Pelosi,et al. Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies , 2021, Frontiers in Physiology.
[6] M. Spraul,et al. NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines. , 2021, Journal of proteome research.
[7] Q. Lu,et al. COVID-19 and autoimmune diseases , 2020, Current opinion in rheumatology.
[8] G. Cappellano,et al. Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2 , 2020, International journal of molecular sciences.
[9] Dain R. Brademan,et al. Large-Scale Multi-omic Analysis of COVID-19 Severity , 2020, Cell Systems.
[10] Kenneth G. C. Smith,et al. Integrative Modeling of Quantitative Plasma Lipoprotein, Metabolic, and Amino Acid Data Reveals a Multiorgan Pathological Signature of SARS-CoV-2 Infection , 2020, Journal of proteome research.
[11] Shelly C. Lu,et al. SARS-CoV-2 Infection Dysregulates the Metabolomic and Lipidomic Profiles of Serum , 2020, iScience.
[12] Gek Huey Chua,et al. Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis , 2020, Cell Metabolism.
[13] E. Hod,et al. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. , 2020, JCI insight.
[14] L. Plantier,et al. The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism , 2020, Scientific Reports.
[15] L. Kucirka,et al. Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure , 2020, Annals of Internal Medicine.
[16] Hong Wang,et al. Plasma metabolomic and lipidomic alterations associated with COVID-19 , 2020, medRxiv.
[17] E. Herker,et al. Whole Lotta Lipids—From HCV RNA Replication to the Mature Viral Particle , 2020, International journal of molecular sciences.
[18] Michael J MacCoss,et al. Skyline for Small Molecules: A Unifying Software Package for Quantitative Metabolomics. , 2020, Journal of proteome research.
[19] G. Gkoutos,et al. Machine learning for the detection of early immunological markers as predictors of multi-organ dysfunction , 2019, Scientific Data.
[20] O. Fiehn,et al. Inborn Errors of Metabolism in the Era of Untargeted Metabolomics and Lipidomics , 2019, Metabolites.
[21] Sanjiv J. Shah,et al. Elevated Plasma Ceramides Are Associated With Antiretroviral Therapy Use and Progression of Carotid Artery Atherosclerosis in HIV Infection , 2019, Circulation.
[22] D. L. Mascarenhas,et al. Lipidomic Analysis Reveals Serum Alteration of Plasmalogens in Patients Infected With ZIKA Virus , 2019, Front. Microbiol..
[23] Kristin E. Burnum-Johnson,et al. Plasma lipidome reveals critical illness and recovery from human Ebola virus disease , 2019, Proceedings of the National Academy of Sciences.
[24] J. Chan,et al. Characterization of the Lipidomic Profile of Human Coronavirus-Infected Cells: Implications for Lipid Metabolism Remodeling upon Coronavirus Replication , 2019, Viruses.
[25] L. Moreno,et al. Ceramide and Regulation of Vascular Tone , 2019, International journal of molecular sciences.
[26] C. Hellerbrand. Inhibition of monoacylglycerol lipase for the treatment of liver disease: tempting but still playing with fire , 2018, Gut.
[27] S. Summers,et al. The ceramide ratio: a predictor of cardiometabolic risk1 , 2018, Journal of Lipid Research.
[28] Xia Zhao,et al. High-resolution lipidomics reveals dysregulation of lipid metabolism in respiratory syncytial virus pneumonia mice , 2018, RSC advances.
[29] T. Standiford,et al. Associations of the plasma lipidome with mortality in the acute respiratory distress syndrome: a longitudinal cohort study , 2018, Respiratory Research.
[30] K. Lauber,et al. Elevated Serum Lysophosphatidylcholine in Patients with Systemic Lupus Erythematosus Impairs Phagocytosis of Necrotic Cells In Vitro , 2018, Front. Immunol..
[31] C. Barbas,et al. Metabolomic-Based Methods in Diagnosis and Monitoring Infection Progression , 2018, Experientia supplementum.
[32] Georg Heinze,et al. Variable selection – A review and recommendations for the practicing statistician , 2018, Biometrical journal. Biometrische Zeitschrift.
[33] Kristin E. Burnum-Johnson,et al. Multi-platform 'Omics Analysis of Human Ebola Virus Disease Pathogenesis. , 2017, Cell host & microbe.
[34] Y. Li,et al. Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection , 2017, Scientific Reports.
[35] N. Mehta,et al. Lipid Abnormalities and Inflammation in HIV Inflection , 2016, Current HIV/AIDS Reports.
[36] Young-Mo Kim,et al. Integrated Omics Analysis of Pathogenic Host Responses during Pandemic H1N1 Influenza Virus Infection: The Crucial Role of Lipid Metabolism. , 2016, Cell host & microbe.
[37] J. Souza-Neto,et al. A Lipidomics Approach in the Characterization of Zika-Infected Mosquito Cells: Potential Targets for Breaking the Transmission Cycle , 2016, PloS one.
[38] Xiaofeng Yang,et al. Lysophospholipids and their G protein-coupled receptors in atherosclerosis. , 2016, Frontiers in bioscience.
[39] Adam D. Kennedy,et al. Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism , 2015, Journal of Inherited Metabolic Disease.
[40] T. Pritts,et al. Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsis , 2015, Journal of Molecular Medicine.
[41] Melinda M. Mulvihill,et al. Therapeutic potential of monoacylglycerol lipase inhibitors. , 2013, Life sciences.
[42] D. Cheillan,et al. Amino acid profiling for the diagnosis of inborn errors of metabolism. , 2011, Methods in molecular biology.
[43] F. Negro. Abnormalities of lipid metabolism in hepatitis C virus infection , 2010, Gut.
[44] E. Gulbins,et al. Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis. , 2010, American journal of respiratory cell and molecular biology.
[45] B. Hurley,et al. Multiple Roles of Phospholipase A2 during Lung Infection and Inflammation , 2008, Infection and Immunity.
[46] John D. Storey. The positive false discovery rate: a Bayesian interpretation and the q-value , 2003 .
[47] G. Schmitz,et al. Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients Published, JLR Papers in Press, January 16, 2003. DOI 10.1194/jlr.M200401-JLR200 , 2003, Journal of Lipid Research.
[48] L. di Marzio,et al. Ceramide concentrations in septic patients: a possible marker of multiple organ dysfunction syndrome. , 1999, Critical care medicine.
[49] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .